Table 1.

Baseline characteristics of postmenopausal women according to cardiovascular disease (CVD) status in the Women's Health Study.

Characteristics	HT nonusers (N=200)
	Cases (n=98)	Controls (n=102)	p-value*
Hormone Therapy (%)
Never	55.4	58.3
Past	44.6	41.7	0.68
Mean Age, years (± SD)	64.8±7.0	65.0±6.8	0.84
Mean BMI (± SD)	28.1±5.9	25.1±4.8	0.006
SHBG, nmol/L†	41.95	48.4	0.05
Testosterone, ng/dL†	19.90	18.10	0.28
Estradiol, pg/mL†	10.25	10.91	0.50
FAI, nmol/L†	0.02	0.01	0.03
FEI, pmol/L†	0.001	0.001	0.51
Hemoglobin A1c, %†	5.20	5.01	0.05

HT= hormone therapy

^†Geometric means.

^*P values were obtained from Paired Student's t-test for continuous variables and Chi-square for categorical variables.